166 related articles for article (PubMed ID: 37180663)
21. [Clinical analysis on adult acute T-lymphoblastic leukemia].
Zhang Q; Zhou CL; Fu MW; Wang JY; Lin D; Liu BC; Li W; Mi YC; Wang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):478-82. PubMed ID: 22541122
[TBL] [Abstract][Full Text] [Related]
22. Prognostic role of Wnt and Fzd gene families in acute myeloid leukaemia.
Dai Y; Cheng Z; Fricke DR; Zhao H; Huang W; Zhong Q; Zhu P; Zhang W; Wu Z; Lin Q; Zhu H; Liu Y; Qian T; Fu L; Cui L; Zeng T
J Cell Mol Med; 2021 Feb; 25(3):1456-1467. PubMed ID: 33417298
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of the FUT family in acute myeloid leukemia.
Dai Y; Cheng Z; Pang Y; Jiao Y; Qian T; Quan L; Cui L; Liu Y; Si C; Chen J; Ye X; Chen J; Shi J; Wu D; Zhang X; Fu L
Cancer Gene Ther; 2020 Feb; 27(1-2):70-80. PubMed ID: 31209266
[TBL] [Abstract][Full Text] [Related]
24. Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment.
Hu GH; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ
BMC Cancer; 2020 Jun; 20(1):553. PubMed ID: 32539815
[TBL] [Abstract][Full Text] [Related]
25. MiR-340 Is a Biomarker for Selecting Treatment Between Chemotherapy and Allogeneic Transplantation in Acute Myeloid Leukemia.
Niu M; Zhang N; Wang R; Shao T; Feng Y; Shen Y; Liu X; Zhao K; Zhu S; Xu L; Yao Y; Xu K
Front Oncol; 2019; 9():1058. PubMed ID: 31681594
[TBL] [Abstract][Full Text] [Related]
26. Stratification of de novo adult acute myelogenous leukemia with adverse-risk karyotype: can we overcome the worse prognosis of adverse-risk group acute myelogenous leukemia with hematopoietic stem cell transplantation?
Yoon JH; Kim HJ; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
Biol Blood Marrow Transplant; 2014 Jan; 20(1):80-8. PubMed ID: 24149098
[TBL] [Abstract][Full Text] [Related]
27. The Superiority of Allogeneic Hematopoietic Stem Cell Transplantation Over Chemotherapy Alone in the Treatment of Acute Myeloid Leukemia Patients with Mixed Lineage Leukemia (MLL) Rearrangements.
Yang H; Huang S; Zhu CY; Gao L; Zhu HY; Lv N; Jing Y; Yu L
Med Sci Monit; 2016 Jul; 22():2315-23. PubMed ID: 27373985
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of Glutamic-Oxaloacetic Transaminase 1 Predicts Poor Prognosis in Acute Myeloid Leukemia.
Cheng Z; Dai Y; Zeng T; Liu Y; Cui L; Qian T; Si C; Huang W; Pang Y; Ye X; Shi J; Fu L
Front Oncol; 2020; 10():379. PubMed ID: 32266153
[TBL] [Abstract][Full Text] [Related]
29. High Expression Levels of
Yang X; Pang Y; Zhang J; Shi J; Zhang X; Zhang G; Yang S; Wang J; Hu K; Wang J; Jing H; Ke X; Fu L
J Cancer; 2019; 10(18):4286-4292. PubMed ID: 31413748
[No Abstract] [Full Text] [Related]
30. [Retrospective Analysis of the Impact of Treatment on Prognosis in 44 Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia].
Chen XP; Lv N; Li YH; Jing Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):14-8. PubMed ID: 26913386
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of Spinster homolog gene family in acute myeloid leukemia.
Huang W; Qian T; Cheng Z; Zeng T; Si C; Liu C; Deng C; Ye X; Liu Y; Cui L; Fu L
J Cancer; 2020; 11(15):4581-4588. PubMed ID: 32489475
[TBL] [Abstract][Full Text] [Related]
32. Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1.
Cheng Z; Dai Y; Pang Y; Jiao Y; Zhao H; Wu S; Zhang L; Zhang Y; Wang X; Wang L; Ma D; Qin T; Hu N; Zhang Y; Hu K; Zhang Q; Shi J; Fu L
Cell Physiol Biochem; 2018; 47(5):1853-1861. PubMed ID: 29961066
[TBL] [Abstract][Full Text] [Related]
33. BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia.
Zhou JD; Zhang TJ; Xu ZJ; Gu Y; Ma JC; Li XX; Guo H; Wen XM; Zhang W; Yang L; Liu XH; Lin J; Qian J
Diagn Pathol; 2019 Jun; 14(1):68. PubMed ID: 31253168
[TBL] [Abstract][Full Text] [Related]
34. The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations.
Zheng WS; Hu YL; Guan LX; Peng B; Wang SY
Hematology; 2021 Dec; 26(1):179-185. PubMed ID: 33594943
[TBL] [Abstract][Full Text] [Related]
35. Clinical Outcomes in Patients with FLT3-ITD-Mutated Relapsed/Refractory Acute Myelogenous Leukemia Undergoing Hematopoietic Stem Cell Transplantation after Quizartinib or Salvage Chemotherapy in the QuANTUM-R Trial.
Ganguly S; Cortes JE; Krämer A; Levis MJ; Martinelli G; Perl AE; Russell NH; Arunachalam M; Santos CD; Gammon G; Lesegretain A; Mires DE; Pham H; Wang Y; Khaled SK
Transplant Cell Ther; 2021 Feb; 27(2):153-162. PubMed ID: 33017662
[TBL] [Abstract][Full Text] [Related]
36. High expression of microRNA-500 is associated with poor prognosis in patients with acute myeloid leukemia receiving allogeneic hematopoietic stem cell transplantation.
Zhang G; Shi J; Yang X; Zhang X; Zhang L; Zhang J; Yang S; Wang J; Hu K; Ke X; Fu L
Oncol Lett; 2019 Jun; 17(6):5815-5820. PubMed ID: 31186809
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy or Allogeneic Stem Cell Transplantation as Salvage Therapy for Patients with Refractory Acute Myeloid Leukemia: A Multicenter Analysis.
Wang ZY; Gao WH; Zhao HJ; Yin CR; Wang ZW; Tian L; Wang L; Wang LN; Jiang JL; Devillier R; Wan M; Wang JM; Huang PP; Blaise D; Hu J
Acta Haematol; 2022; 145(4):419-429. PubMed ID: 35231903
[TBL] [Abstract][Full Text] [Related]
38. Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations.
Xu Y; Sun Y; Shen H; Ding L; Yang Z; Qiu H; Sun A; Chen S; Wu D
Am J Hematol; 2015 Nov; 90(11):992-7. PubMed ID: 26223865
[TBL] [Abstract][Full Text] [Related]
39. High Expression of RhoBTB3 Predicts Favorable Chemothrapy Outcomes in non-M3 Acute Myeloid Leukemia.
Yang SH; Liu W; Peng J; Xu YJ; Liu YF; Li Y; Peng MY; Ou-Yang Z; Chen C; Liu EY
J Cancer; 2021; 12(14):4229-4239. PubMed ID: 34093823
[No Abstract] [Full Text] [Related]
40. FLT3-ITD Allelic Ratio and NPM1 Mutation Do Not Impact Outcomes in Acute Myeloid Leukemia Patients with FLT3-ITD after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Propensity Score- Matching Study.
Zhou C; Zheng F; Xu L; Zhang X; Chang Y; Mo X; Sun Y; Huang X; Wang Y
Transplant Cell Ther; 2023 Jul; 29(7):456.e1-456.e11. PubMed ID: 37028555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
